温肾强骨方对肿瘤中后期并发骨质疏松症患者骨密度、骨形成及骨吸收的影响

被引:6
作者
刘峰
孙庆山
白田雨
机构
[1] 山东省立第三医院
关键词
骨质疏松症; 脾肾阳虚证; 温肾强骨方; 骨形成; 骨密度; 骨吸收;
D O I
暂无
中图分类号
R273 [中医肿瘤科]; R259 [现代医学内科疾病];
学科分类号
100201 [内科学]; 100502 [中医临床基础];
摘要
目的:探究温肾强骨方对肿瘤中后期并发骨质疏松症患者骨密度、骨形成及骨吸收的影响。方法:按照患者用药意向将154例肿瘤中后期并发骨质疏松症患者分为对照组、治疗组。对照组75例给予西医治疗;治疗组79例,在对照组基础上给予温肾强骨方治疗。比较两组患者骨形成相关指标、临床疗效、骨吸收指标、骨密度情况、中医症状评分、血清生化指标。结果:治疗组患者总有效率93.67%高于对照组的80.00%(P<0.05)。治疗前,两组患者中医症状评分、骨密度、骨形成相关指标、骨吸收指标比较,差异无统计学意义(均P>0.05)。治疗后,两组以上指标均较治疗前改善,且治疗组较对照组改善更为显著,组间比较差异有统计学意义(均P<0.05)。结论:温肾强骨方对肿瘤中后期并发骨质疏松症患者具有较好的治疗效果,且该方通过改善患者骨密度、骨形成及骨吸收相关指标能够缓解临床症状。
引用
收藏
页码:712 / 715
页数:4
相关论文
共 22 条
[1]
益肾健骨方治疗早期2型糖尿病肾病合并骨质疏松症肾虚血瘀证的临床疗效观察 [D]. 
史孟瑄 .
南京中医药大学,
2018
[2]
The Influence of Osteoporosis Knowledge; Health belief and Self-efficacy on Osteoporosis Prevention Behavior Osteoporosis in Middle-aged Men.[J].Ji Young Kim;Youngran Yang;Myoungha Lee.한국간호과학회 학술대회.2019,
[3]
Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis..[J].Gan Donghao;Xu Xiaowei;Chen Deqiang;Feng Peng;Xu Zhanwang.Medical science monitor : international medical journal of experimental and clinical research.2019,
[4]
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study [J].
Silverman, Stuart L. ;
Siris, E. ;
Belazi, D. ;
Recknor, C. ;
Papaioannou, A. ;
Brown, J. P. ;
Gold, D. T. ;
Lewiecki, E. M. ;
Quinn, G. ;
Balasubramanian, A. ;
Yue, S. ;
Stolshek, B. ;
Kendler, D. L. .
ARCHIVES OF OSTEOPOROSIS, 2018, 13 (01)
[5]
Erratum: American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis.[J].Jennifer M. Grossman;Rebecca Gordon;Veena K. Ranganath;Chad Deal;Liron Caplan;Weiling Chen;Jeffrey R. Curtis;Daniel E. Furst;Maureen McMahon;Nivedita M. Patkar;Elizabeth Volkmann;Kenneth G. Saag.Arthritis Care & Research.2012, 3
[6]
Safety considerations with bisphosphonates for the treatment of osteoporosis [J].
Strampel, William ;
Emkey, Ronald ;
Civitelli, Roberto .
DRUG SAFETY, 2007, 30 (09) :755-763
[7]
EFFECT OF SALCATONIN GIVEN INTRANASALLY ON BONE MASS AND FRACTURE RATES IN ESTABLISHED OSTEOPOROSIS - A DOSE-RESPONSE STUDY [J].
OVERGAARD, K ;
HANSEN, MA ;
JENSEN, SB ;
CHRISTIANSEN, C .
BRITISH MEDICAL JOURNAL, 1992, 305 (6853) :556-561
[8]
健脾补肾益骨方联合阿仑膦酸钠对乳腺癌内分泌治疗致骨质疏松患者骨密度和骨代谢的影响 [J].
章茂友 .
中国中医药科技, 2019, 26 (06) :899-901
[9]
补肾益骨方辨证加减联合碳酸钙D3片对围绝经期骨质疏松症患者疗效及其对骨代谢指标的影响 [J].
战美玲 ;
田永萍 .
中国中医基础医学杂志, 2019, 25 (08) :1115-1118
[10]
补肾强骨方联合依降钙素对骨质疏松症患者的临床疗效 [J].
王新春 ;
陶东红 ;
王松 .
中成药, 2019, (08) :2014-2016